Pact With NCI Expands Veterans' Access to Trials

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 6 No 2
Volume 6
Issue 2

BETHESDA, Md--In a move designed to increase the pool of patients available for clinical trials, the National Cancer Institute has forged an agreement with the Department of Veterans Affairs that will increase the ability of veterans to enroll in phase I, II, and III studies.

BETHESDA, Md--In a move designed to increase the pool of patients availablefor clinical trials, the National Cancer Institute has forged an agreementwith the Department of Veterans Affairs that will increase the abilityof veterans to enroll in phase I, II, and III studies.

Under the agreement, the VA will provide medical coverage for eligibleveterans who participate in NCI-supported studies at non-VA facilities.The pact also envisions that more NCI studies will be conducted in VA hospitalsand clinics.

"Developing an expanded pool of VA cancer researchers will strengthenour clinical research program across the board," said Robert Wittes,MD, director of NCI's Division of Cancer Treatment, Diagnosis, and Centers.

Recent Videos
Certain bridging therapies and abundant steroid use may complicate the T-cell collection process during CAR T therapy.
Pancreatic cancer is projected to become the second-leading cause of cancer-related deaths by 2030 in the United States.
2 experts are featured in this video
2 experts are featured in this video
2 experts are featured in this video
4 KOLs are featured in this series.
Educating community practices on CAR T referral and sequencing treatment strategies may help increase CAR T utilization.
The FirstLook liquid biopsy, when used as an adjunct to low-dose CT, may help to address the unmet need of low lung cancer screening utilization.
Related Content